• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Intel, Samsung Collaborate on AI-Powered Fetal Ultrasound Smart Workflow

Share:

September 16, 2020

Highlights on this story:
  • Samsung Medison and Intel collaborate on AI-powered new smart workflow solutions to improve obstetric measurements that contribute to maternal and fetal safety.
  • BiometryAssist automates and standardizes fetal measurements in approximately 85 milliseconds with a single click, providing over 97% accuracy.
  • BiometryAssist and LaborAssist are already in use in 80 countries, including the United States, Korea, Italy, France, Brazil and Russia. The solutions received Class 2 clearance by the FDA in 2020.

Today, Samsung Medison and Intel announced a new collaboration on new smart workflow solutions to improve obstetric measurements that contribute to maternal and fetal safety and can help save lives. Using an Intel® Core™ i3 processor, the Intel® Distribution of OpenVINO™ toolkit and OpenCV library, Samsung Medison’s BiometryAssist™ automates and simplifies fetal measurements, while LaborAssist™ automatically estimates the fetal angle of progression (AoP) during labor for a complete understanding of a patient’s birthing progress, without the need for invasive digital vaginal exams.

How It Works

BiometryAssist automates and standardizes fetal measurements in approximately 85 milliseconds with a single click, providing over 97% accuracy. This allows doctors to spend more time talking with their patients while also standardizing fetal measurements, which have historically proved challenging to accurately provide. With BiometryAssist, physicians can quickly verify consistent measurements for high volumes of patients.

During labor, LaborAssist helps physicians estimate fetal AOP and head direction. This enables both the physician and patient to understand the fetal descent and labor process and determine the best method for delivery. There is always risk with delivery and a slowing progress could result in issues for the baby. Obtaining more accurate and real-time progression of labor can help physicians determine the best mode of delivery and potentially help reduce the number of unnecessary cesarean sections.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“LaborAssist provides automatic measurement of the angle of progression as well as information pertaining to fetal head direction and estimated head station. So it is useful for explaining to the patient and her family how the labor is progressing, using ultrasound images which show the change of head station during labor. It is expected to be of great assistance in the assessment of labor progression and decision-making for delivery,” said Professor Min Jeong Oh, MD, PhD, Department of Obstetrics and Gynecology, Korea University Guro Hospital in Seoul, Korea.

Why It Matters

According to the World Health Organization, about 295,000 women died during and following pregnancy and childbirth in 2017, even as maternal mortality rates decreased. While every pregnancy and birth is unique, most maternal deaths are preventable. Research from the Perinatal Institute found that tracking fetal growth is essential for good prenatal care and can help prevent stillbirths when physicians are able to recognize growth restrictions.

“At Intel, we are focused on creating and enabling world-changing technology that enriches the lives of every person on Earth,” said Claire Celeste Carnes, strategic marketing director for Health and Life Sciences at Intel. “We are working with companies like Samsung Medison to adopt the latest technologies in ways that enhance the patient safety and improve clinical workflows, in this case for the important and time-sensitive care provided during pregnancy and delivery.”

Availability

BiometryAssist and LaborAssist are already in use in 80 countries, including the United States, Korea, Italy, France, Brazil and Russia. The solutions received Class 2 clearance by the FDA in 2020. Intel and Samsung Medison will continue to collaborate to advance the state of the art in ultrasounds by accelerating AI and leveraging advanced technology in Samsung Medison’s next-generation ultrasound solutions, including Nerve Tracking, SW Beamforming and AI Module.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Walmart Looks to Virtual Care with Acquisition of Telemedicine Company MeMDWalmart Looks to Virtual Care with Acquisition of Telemedicine Company MeMD
  • EndoWays LTD, Developer of the First Disposable Robot for the Cathlab, Acquired by AscendumEndoWays LTD, Developer of the First Disposable Robot for the Cathlab, Acquired by Ascendum
  • HealthTech Arkansas Unveils Latest Cohort of 5 Digital Health StartupsHealthTech Arkansas Unveils Latest Cohort of 5 Digital Health Startups
  • Medical Properties Trust Completes A$1.2 Billion Investment in Eleven Healthscope HospitalsMedical Properties Trust Completes A$1.2 Billion Investment in Eleven Healthscope Hospitals
  • Covalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United StatesCovalon Announces Definitive Agreement to Acquire AquaGuard and its Specialized Salesforce Capable of Selling Covalon’s Products Throughout the United States
  • Health Records on iPhoneⓇ Available to Consumers Enrolled in MEDITECH’s Patient PortalHealth Records on iPhoneⓇ Available to Consumers Enrolled in MEDITECH’s Patient Portal
  • New clinical trial rules to boost growth of clinical research industryNew clinical trial rules to boost growth of clinical research industry
  • Alight to acquire Hodges-Mace to enhance its health and voluntary benefit capabilities and expand suite of solutions for employers of all sizesAlight to acquire Hodges-Mace to enhance its health and voluntary benefit capabilities and expand suite of solutions for employers of all sizes

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications